STOCK TITAN

Grace Therapeutics (GRCE) investor group reports 6.75% stake via convertibles

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Grace Therapeutics, Inc. has a significant shareholder group reporting beneficial ownership of its common stock. As of June 30, 2026, Nantahala Capital Management, LLC, together with Wilmot B. Harkey and Daniel Mack, may be deemed to beneficially own 1,178,203 shares of common stock, representing 6.75% of the outstanding class. These shares are held by funds and separately managed accounts under Nantahala’s control and are all issuable within sixty days upon exercise of convertible securities. The reporting persons have no sole voting or dispositive power but share voting and dispositive power over the same 1,178,203 shares.

Positive

  • None.

Negative

  • None.
Beneficially owned shares 1,178,203 shares Shares that may be acquired within sixty days through convertible securities as of June 30, 2026
Percent of class 6.75% Beneficial ownership percentage for each of the three reporting persons as of June 30, 2026
Shared voting power 1,178,203 shares Shares over which each reporting person has shared power to vote or direct the vote
Sole voting power 0 shares Shares over which each reporting person has sole power to vote or direct the vote
Shared dispositive power 1,178,203 shares Shares over which each reporting person has shared power to dispose or direct disposition
beneficial owner financial
"Nantahala may be deemed to be the beneficial owner of 1,178,203 Shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
shared voting power financial
"Shared Voting Power 1,178,203.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 1,178,203.00"
convertible securities financial
"Shares which may be acquired by the Reporting Persons within sixty days through the exercise of convertible securities"
Convertible securities are bonds or preferred shares that can be exchanged for a company’s common stock at a predetermined price or under specified conditions. They matter because they combine the steadiness of a loan or fixed dividend with the potential upside of ownership; like a safety‑net that carries a one‑time ticket to become a shareholder, they affect expected returns and can dilute existing stock if converted.
control person financial
"Each of Messrs. Harkey and Mack is filing this as a control person in respect of shares"
A control person is an individual or entity that can significantly influence a company’s decisions and direction through ownership, voting power, or contractual rights—think of them as the captain who can steer the ship. Investors care because a control person’s choices affect corporate strategy, board appointments, and transactions that can raise or lower a stock’s value, and they often carry additional legal responsibilities and disclosure requirements to protect other shareholders.
investment adviser financial
"Nantahala, an investment adviser as described in ss. 240.13d-1(b)(1)(ii)(E)"
An investment adviser is a person or firm that professionally manages money and gives recommendations about buying, selling, or holding investments. Like a financial coach or guide, they have a legal duty to act in a client's best financial interest, so their advice, fees and potential conflicts can directly affect returns and risk — making their role important for investors who want informed, accountable help with portfolios.

FAQ

What percentage of Grace Therapeutics (GRCE) does Nantahala Capital beneficially own?

Nantahala Capital Management, LLC and related reporting persons may be deemed to beneficially own 6.75% of Grace Therapeutics’ common stock, based on 1,178,203 shares as of June 30, 2026, held through funds and managed accounts.

How many Grace Therapeutics (GRCE) shares are reported by Nantahala Capital?

The reporting group lists beneficial ownership of 1,178,203 shares of Grace Therapeutics common stock. All of these shares may be acquired within sixty days through the exercise of convertible securities held by funds and accounts under Nantahala’s control.

Do Nantahala and its principals have sole or shared voting power in GRCE?

The reporting persons have 0 shares with sole voting power and 1,178,203 shares with shared voting power. They similarly report no sole dispositive power and shared dispositive power over the same 1,178,203 shares.

Who are the reporting persons in this Grace Therapeutics (GRCE) Schedule 13G/A?

The reporting persons are Nantahala Capital Management, LLC, and its managing members Wilmot B. Harkey and Daniel Mack. Each may be deemed a beneficial owner of the 1,178,203 Grace Therapeutics shares held by Nantahala-controlled funds and accounts.

Are the reported GRCE shares currently outstanding or issuable from convertibles?

The reported 1,178,203 shares are tied to convertible securities that the reporting persons state may be acquired within sixty days. This means the stake reflects shares issuable upon conversion, not directly held common shares alone.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





00439U104

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Nantahala Capital Management, LLC
Signature:/s/ Taki Vasilakis
Name/Title:Taki Vasilakis / Chief Compliance Officer
Date:08/14/2026
Wilmot B. Harkey
Signature:/s/ Wilmot B. Harkey
Name/Title:Wilmot B. Harkey
Date:08/14/2026
Daniel Mack
Signature:/s/ Daniel Mack
Name/Title:Daniel Mack
Date:08/14/2026